Sarsia Management AS
Venture capitalBergen · Seed–Series A · 14 people tracked
Investment thesis
Sarsia is an early-stage venture capital firm investing across two main areas: life sciences, targeting unmet medical needs where capital and expertise can turn laboratory research into effective patient treatments; and technology, energy and sustainability, backing founders and technologies that can accelerate the green transition and build sustainable companies. The firm emphasizes technologies that improve quality of life and society while reducing negative environmental impact, connecting strong science and solutions with competent capital. Drawing on a team with diverse backgrounds and perspectives, Sarsia takes on risk to create value and is one of the top-performing early-stage venture funds in the Nordic region.
Source: firm website, verified Aug 3, 2026.
Team · 14 people
from the firm's website & curated & public directories
What they invest in
from 10 of 47 portfolio companiesHealthtech ×6Biotech ×4Medical Devices ×4AI & Machine Learning ×3Cleantech ×3Climate Tech ×2Energy ×2Circular Economy ×1
HQs:Norway×6Sweden×1United States×1
Investments · 47 tracked
founders shown can be your intro pathCaedo Oncology develops therapeutic antibodies for cancer treatment, leveraging deep immunology and antibody engineering expertise.
BiotechHealthtechLongevityMedical DevicesOslo, NO
Kjetil Hestdal(Co-founder and CEO)
Co-investorsFarvatn Venture
Completed patient enrollment in its Phase 2 AURORA trial.
Co-investorsP53 Invest
Co-investorsShift4Good
Coegin Pharma develops and commercializes advanced cosmetic peptide technologies for hair and skin care, targeting the global longevity and wellness market.
BiotechConsumerHealthtechWellness & FitnessLund, SE
Co-investorsVentac Partners
Elekt provides a white-label customer platform for electricity and grid utilities, including a consumer app, a business portal, and a CRM/marketing hub for the utility's own team.
EnergyEnterprise SoftwareSaaS
Heimdall Power develops advanced sensors and software to enhance power grid visibility, safety, and responsiveness for grid operators globally.
AI & Machine LearningCleantechEnergyIoTCharlotte, US
Jørgen Festervoll(CEO)
Co-investorsEviny VenturesSprettert
Nisonic develops FAST-ICP software that uses transorbital ultrasound imaging and machine learning to non-invasively detect raised intracranial pressure by measuring optic nerve sheath properties.
AI & Machine LearningHealthtechMedical DevicesTrondheim, NO
Co-investorsHadean VenturesInvestinor
Oculaudio develops hearing aids designed for aesthetic appeal and user-friendliness, targeting people with hearing loss who experience fatigue from concentration required in daily listening situations.
AI & Machine LearningHardwareHealthtechMedical Devices
Tom Austad
Pacertool develops a precision medicine system (PaCRTool) focused on heart failure therapy, aimed at helping clinicians select suitable patients, optimize treatment, and measure response.
Digital HealthHealthtechMedical Devices
Co-investorsFarvatn Venture
Pluvia Biotech is a University of Bergen spin-out developing small molecule pharmacological chaperones that stabilize and correct misfolded proteins to rescue enzymatic activity in rare genetic loss-of-function disorders.
BiotechDeep TechHealthtechBergen, NO
Aurora Martinez(CTO)Willem van Weperen(CEO)Torgeir Vaage(CFO)
Co-investorsInvestinor
Completed the final patient procedure in a study of its SonoWand-related product.
Sarsia is an early-stage venture capital firm that invests in life sciences companies addressing unmet medical needs and technology companies advancing the green transition and sustainability.
BiotechCleantechClimate Tech
High accuracy clamp-on flow rate and phase fraction meter for gas, oil, water and drilling mud systems.
Co-investorsProVenture
Frequently asked questions
- How many investments has Sarsia Management AS made?
- Sarsia Management AS has 47 tracked investments.
- What stage does Sarsia Management AS invest at?
- Sarsia Management AS invests at the Seed, Series A stages.
- What is Sarsia Management AS's typical check size?
- Sarsia Management AS typically writes checks of $190K – $475K.
- What sectors does Sarsia Management AS focus on?
- Sarsia Management AS focuses on AI & Machine Learning, Biotech, Cleantech, Climate Tech, Deep Tech, Energy, Hardware, Healthtech, IoT, Medical Devices, New Materials, Semiconductors.
- Where is Sarsia Management AS located?
- Sarsia Management AS is headquartered in Bergen, NO.
- Does Sarsia Management AS lead rounds?
- Yes, Sarsia Management AS leads investment rounds.
- Who does Sarsia Management AS co-invest with?
- Sarsia Management AS most often shares deals with Farvatn Venture, Eviny Ventures, Hadean Ventures, among 8 tracked co-investors.
Similar investors
Qbic is an inter-university venture capital fund that turns technological breakthroughs from its partner universities, research institutes and hospitals into sustainable businesses.
Everywhere Ventures is an early-stage venture firm, backed by a community of founders and operators as LPs, that writes early checks (including pre-seed) into startups across many sectors and geographies.
Range is a venture capital firm that invests in founders building novel solutions in overlooked or challenging categories. The firm focuses on consensus founders with unique insights, backing companies at various stages across diverse sectors.
Cowin Capital Group is a Chinese investment management firm with extensive experience investing in and exiting technology, healthcare, and industrial companies, many of which have gone public on Chinese and Hong Kong exchanges.
BDC (Business Development Bank of Canada) is a bank supporting Canadian small and medium-sized businesses across all industries and growth stages with financing and advisory services.